$5.59 Billion is the total value of ARMISTICE CAPITAL, LLC's 116 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
AUUDW | Exit | AUDDIA INC*w exp 10/17/202 | $0 | – | -30,400 | -100.0% | 0.00% | – |
CUENW | Exit | CUENTAS INC*w exp 99/99/999 | $0 | – | -50,000 | -100.0% | -0.00% | – |
RZLT | Exit | REZOLUTE INC | $0 | – | -288,000 | -100.0% | -0.05% | – |
PBPB | Exit | POTBELLY CORP | $0 | – | -407,099 | -100.0% | -0.06% | – |
Exit | PREDICTIVE ONCOLOGY INC | $0 | – | -2,051,284 | -100.0% | -0.06% | – | |
FTEK | Exit | FUEL TECH INC | $0 | – | -850,000 | -100.0% | -0.06% | – |
Exit | OBALON THERAPEUTICS INC | $0 | – | -1,100,000 | -100.0% | -0.07% | – | |
PRFX | Exit | PAINREFORM LTD | $0 | – | -839,346 | -100.0% | -0.08% | – |
HOTH | Exit | HOTH THERAPEUTICS INC | $0 | – | -2,270,000 | -100.0% | -0.10% | – |
RWLK | Exit | REWALK ROBOTICS LTD | $0 | – | -1,911,264 | -100.0% | -0.11% | – |
PLAN | Exit | ANAPLAN INC | $0 | – | -132,000 | -100.0% | -0.16% | – |
DT | Exit | DYNATRACE INC | $0 | – | -150,000 | -100.0% | -0.17% | – |
ALT | Exit | ALTIMMUNE INC | $0 | – | -536,000 | -100.0% | -0.17% | – |
SILK | Exit | SILK RD MED INC | $0 | – | -150,000 | -100.0% | -0.17% | – |
EGRX | Exit | EAGLE PHARMACEUTICALS INC | $0 | – | -192,000 | -100.0% | -0.18% | – |
WDAY | Exit | WORKDAY INCcl a | $0 | – | -35,000 | -100.0% | -0.20% | – |
TNDM | Exit | TANDEM DIABETES CARE INC | $0 | – | -100,000 | -100.0% | -0.20% | – |
BGS | Exit | B & G FOODS INC NEW | $0 | – | -288,000 | -100.0% | -0.20% | – |
AEO | Exit | AMERICAN EAGLE OUTFITTERS IN | $0 | – | -387,995 | -100.0% | -0.26% | – |
UAA | Exit | UNDER ARMOUR INCcl a | $0 | – | -566,881 | -100.0% | -0.29% | – |
POOL | Exit | POOL CORP | $0 | – | -36,875 | -100.0% | -0.29% | – |
FIVE | Exit | FIVE BELOW INC | $0 | – | -66,800 | -100.0% | -0.29% | – |
GPS | Exit | GAP INC | $0 | – | -515,617 | -100.0% | -0.35% | – |
AVTR | Exit | AVANTOR INC | $0 | – | -636,000 | -100.0% | -0.42% | – |
POST | Exit | POST HLDGS INC | $0 | – | -188,000 | -100.0% | -0.46% | – |
TSCO | Exit | TRACTOR SUPPLY CO | $0 | – | -132,737 | -100.0% | -0.54% | – |
ADBE | Exit | ADOBE SYSTEMS INCORPORATED | $0 | – | -54,000 | -100.0% | -0.59% | – |
RL | Exit | RALPH LAUREN CORPcl a | $0 | – | -290,517 | -100.0% | -0.82% | – |
NKE | Exit | NIKE INCcl b | $0 | – | -322,491 | -100.0% | -0.98% | – |
AAP | Exit | ADVANCE AUTO PARTS INC | $0 | – | -273,469 | -100.0% | -1.15% | – |
LNTH | Exit | LANTHEUS HLDGS INC | $0 | – | -2,700,000 | -100.0% | -1.32% | – |
TJX | Exit | TJX COS INC NEW | $0 | – | -1,128,122 | -100.0% | -1.71% | – |
IWM | Exit | ISHARES TRput | $0 | – | -2,000,000 | -100.0% | -10.14% | – |
SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -2,000,000 | -100.0% | -18.20% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ENANTA PHARMACEUTICALS INC | 30 | Q3 2023 | 2.7% |
SPDR S&P 500 ETF TR | 28 | Q3 2023 | 29.5% |
MADRIGAL PHARMACEUTICALS INC | 27 | Q3 2023 | 2.9% |
VANDA PHARMACEUTICALS INC | 26 | Q3 2021 | 9.4% |
REGENERON PHARMACEUTICALS | 25 | Q3 2023 | 3.2% |
ENERGIZER HLDGS INC NEW | 22 | Q2 2023 | 3.7% |
ANTARES PHARMA INC | 21 | Q3 2020 | 6.6% |
INCYTE CORP | 21 | Q3 2023 | 2.8% |
VOYAGER THERAPEUTICS INC | 21 | Q3 2023 | 2.0% |
BLUEBIRD BIO INC | 20 | Q4 2021 | 1.8% |
View ARMISTICE CAPITAL, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Avalo Therapeutics, Inc. | June 28, 2023 | 588,850 | 4.7% |
Addex Therapeutics Ltd. | February 16, 2023 | 675,295 | 5.0% |
Arcadia Biosciences, Inc. | February 14, 2023 | 2,675,409 | 10.0% |
Avinger Inc | February 14, 2023 | 789,400 | 10.0% |
Baudax Bio, Inc. | February 14, 2023 | 1,165,709 | 5.0% |
BIORA THERAPEUTICS, INC. | February 14, 2023 | 12,989,648 | 5.7% |
Bit Digital, Inc | February 14, 2023 | 3,161,889 | 3.7% |
Bruush Oral Care Inc. | February 14, 2023 | 1,122,922 | 10.0% |
CATALYST PHARMACEUTICALS, INC.Sold out | February 14, 2023 | 0 | 0.0% |
Clarus Therapeutics Holdings, Inc. | February 14, 2023 | 2,732,169 | 5.0% |
View ARMISTICE CAPITAL, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
View ARMISTICE CAPITAL, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.